Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients

Experience with the mTOR Inhibitor Everolimus in Pediatric Liver Graft Recipients

Introduction: Immunosuppression after pediatric liver transplantation remains a major challenge. MTOR inhibitors provide a promising therapeutic approach in combination with reduced CNI after transplantation. However, there are still few data regarding their use in children. Patients: We analyzed 37...

Full description

Bibliographic Details
Main Authors: Mathis Wehming, Dorothée Krebs-Schmitt, Andrea Briem-Richter, Bianca Hegen, Florian Brinkert, Lutz Fischer, Enke Grabhorn
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Children
Subjects:
pediatric liver transplantation
graft dysfunction
immunosuppressive therapy
renal impairment
malignancy
Online Access:https://www.mdpi.com/2227-9067/10/2/367

Internet

https://www.mdpi.com/2227-9067/10/2/367

Similar Items